Medications for Schizophrenia

16 results
  • abilify - aripiprazole tablet

    (Aripiprazole)
    Otsuka America Pharmaceutical, Inc.
    Abilify (aripiprazole) is indicated for schizophrenia, acute manic and mixed episodes of Bipolar I Disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and Tourette's Disorder.
  • abilify asimtufii - aripiprazole injection, suspension, extended release

    (Aripiprazole)
    Otsuka America Pharmaceutical, Inc
    Abilify Asimtufii treats schizophrenia in adults and is used as maintenance monotherapy for bipolar I disorder in adults.
  • abilify maintena - aripiprazole

    (Aripiprazole)
    Otsuka America Pharmaceutical, Inc.
    Abilify Maintena (aripiprazole) is an injectable antipsychotic indicated for treating schizophrenia in adults and for maintenance monotherapy treatment of bipolar I disorder in adults.
  • caplyta - lumateperone capsule

    (Lumateperone)
    Intra-Cellular Therapies, Inc
    Caplyta treats schizophrenia in adults, depressive episodes associated with bipolar I or II disorder (as monotherapy or adjunctive therapy with lithium or valproate), and major depressive disorder as adjunctive therapy with antidepressants.
  • fanapt - iloperidone tablet

    (Iloperidone)
    Vanda Pharmaceuticals Inc.
    Fanapt treats schizophrenia in adults and is used for acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
  • geodon - ziprasidone hydrochloride capsule

    (Ziprasidone Hydrochloride)
    Roerig
    Geodon treats schizophrenia and bipolar I disorder (manic or mixed episodes) in adults. Also used as adjunct maintenance therapy with lithium or valproate for bipolar I disorder. Intramuscular form treats acute agitation in schizophrenic patients.
  • igalmi - dexmedetomidine film

    (Dexmedetomidine)
    Bioxcel Therapeutics, Inc.
    IGALMI is indicated for acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. Safety and effectiveness beyond 24 hours from the first dose have not been established.